The DNAJC30 gene helps mitochondria, the parts of cells that make energy, keep an energy pathway called complex I working properly. This gene plays an important role in repairing or replacing worn complex I parts, especially in cells with high energy needs such as those in the optic nerve. If you carry a harmful variant in both copies of the gene, energy production can fall and lead to DNAJC30-related Leber hereditary optic neuropathy, which often causes painless central vision loss. DNAJC30 is mainly known in medical genetics rather than popular culture.
What is a gene?
A gene is a section of DNA that gives your cells instructions to make molecules or direct processes in the body. Some genes hold the information needed to produce proteins, the parts of cells that carry out much of the work. Other genes mainly regulate when certain processes happen, where they take place, and how strongly they are active. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medicines. To explore this topic in more detail, you can read more in the LearnHub.
Overview
DNAJC30Gene function
What if the gene works
The DNAJC30 gene helps mitochondria, the parts of cells that make energy, keep a key energy process working well. This supports steady energy supply, especially in tissues with high needs like the eyes and nervous system.
Risk
What if the gene does not work
When the DNAJC30 gene does not work properly, people can develop inherited optic nerve disease with central vision loss, often starting in adolescence or adulthood. Milder and more severe variants can influence onset, severity, and the chance of recovery.
Treatment
What does that mean for your treatment
No treatment or management approach specific to the DNAJC30 gene is currently established. In research on DNAJC30-related optic neuropathy, idebenone and other treatments that support mitochondrial function are being studied, but treatment choices are still guided by the clinical condition rather than by the DNAJC30 gene itself.
Conditions associated with DNAJC30
Gene function
What if the gene works
Your cells need a steady energy supply for everyday work. The DNAJC30 gene helps mitochondria, the parts of cells that make most of that energy, run smoothly. It is especially involved in keeping one key step in energy production efficient. This supports normal cell activity across the body.
The DNAJC30 gene supports complex I (one of the main parts of the mitochondrial energy pathway). This helps cells turn nutrients and oxygen into usable energy for everyday work.
Its protein helps maintain and refresh parts of complex I as they wear with normal use. This is part of how the DNAJC30 gene helps mitochondria make energy in a steady, reliable way.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including differences in appearance, metabolism, and the way the body reacts to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant changes how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the DNAJC30 gene can weaken the DNAJC30 protein or reduce how well it helps repair mitochondrial complex I, a key energy making system in cells. This helps explain how DNAJC30 gene variants affect protein function: some changes leave partial activity, while more disruptive variants can cause a much larger loss of function. When the functional loss is greater, optic nerve disease linked to the DNAJC30 gene may appear earlier or be more pronounced.
How variants are linked to conditions
Pathogenic variants in the DNAJC30 gene are a confirmed cause of autosomal recessive Leber hereditary optic neuropathy, an inherited condition that leads to central vision loss. Among DNAJC30 gene variants linked to vision loss, this is the main well-established diagnosis. Symptoms often begin in the teens or young adulthood and may affect both eyes over time.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and are widely found across the general population. Most do not directly affect health and simply represent normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a firm diagnosis, particularly when several genes and environmental influences play a role. Still, in some situations, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with changes in the DNAJC30 gene linked to inherited optic nerve disease, smoking and heavy alcohol use are thought to increase the chance of vision loss or bring it on earlier. Risk can also vary within families, so the gene change itself remains the main factor.
Inheritance of DNAJC30 variants
DNAJC30-related conditions are inherited in an autosomal recessive pattern. This means a person usually inherits one DNAJC30 gene variant from each parent, and both copies need to carry a disease-causing variant for the condition to develop. Parents who each carry one variant are typically unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is also a carrier, and a 25% chance of having a child with no familial variant. In practical terms, how DNAJC30 gene variants are inherited is the same for sons and daughters because this gene is on an autosome, not a sex chromosome.
What does my DNAJC30 result mean for my family?
For DNAJC30, the main confirmed family pattern is recessive. This usually means parents can be healthy carriers, and brothers or sisters may also be carriers or, less often, have the same condition. Close relatives may want to learn whether the family carries the same DNAJC30 change, especially if there is vision loss in the family.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for DNAJC30 variants is usually done on a blood or saliva sample. A lab reads the DNA in the DNAJC30 gene to look for changes that may help explain symptoms, confirm an inherited condition, or clarify whether family members may also carry the same variant.
When should I consider getting a genetic test?
Consider testing for the DNAJC30 gene if you or a close relative has unexplained, usually painless central vision loss, especially starting in the teens or young adulthood. A harmful change in this gene can confirm an inherited optic nerve condition and help clarify the chance that brothers, sisters, or future children could also be affected.
A genetic result is only one part of your health story
Genetic test results can be informative, yet how much they reveal varies by the condition and the specific type of variant. Over time, the way the body functions is also shaped by factors such as lifestyle, environment, age, and medical history. In some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or reacts to it at its target. This helps explain why the same treatment works well for one person, has little effect in another, or causes more side effects in someone else. These differences are common and are one reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. By looking at links between genes and drugs, it helps clarify why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body processes it. This information can support more informed and individualized treatment decisions. To explore this topic further, you can learn more in the LearnHub.
Drugs influenced by the DNAJC30 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about medicines, side effects, or changes in your health are best discussed with your doctor.
History
DNAJC30 entered the medical literature relatively recently, as improved genetic testing made it easier to link specific inherited patterns with optic nerve disease. In recent decades, awareness of this gene’s role has grown. Researchers first recognized DNAJC30 through studies of families with Leber hereditary optic neuropathy, especially when the usual mitochondrial causes were not found. That work showed that some people with this condition had changes in the DNAJC30 gene instead, which broadened how clinicians understood inherited optic neuropathy. From these first observations, research expanded steadily, and DNAJC30 is now part of the modern genetic picture of this condition.